AUTOFLEET
18.3.2021 06:02:08 CET | Business Wire | Press release
Autofleet , a provider of AI-powered fleet optimization solutions, was selected by Keolis , a public transport operator, to provide its platform for an autonomous electric vehicle (AEV) project in Gothenburg, Sweden. Shuttle operation began on January 18, 2021 on behalf of local public transport authority Västtrafik. The autonomous shuttle service is the first project in an ongoing collaboration to utilize Autofleet’s platform for management of Keolis’ new mobility solutions.
The shuttle service, which is integrated into the city of Gothenburg’s public transportation network as line 56, will serve a route that covers industrial and residential sites using two autonomous electric shuttles manufactured by Navya. Designed to operate in conditions including sub-zero temperatures and snow, this autonomous electric shuttle service is the city’s most advanced mobility project to-date.
Autofleet’s platform aggregates and analyzes granular shuttle data through an integration with Navya’s API in real time to produce actionable insights for operators around the project’s performance. The interface tracks shuttles at the individual sensor level and continually provides data such as station and passenger usage, allowing Keolis to gain clear insights for optimization and improvement of the service. Automated notification and alerting capabilities keep the operational teams aware of field events as they occur. In addition, the Autofleet driver app allows safety operators to track and share reports with their team in a single interface.
Autofleet’s platform is agnostic to the vehicle manufacturer or vehicle type. For their continued work with Autofleet, Keolis is able to integrate autonomous shuttles and electric or internal combustion engine-powered vehicles into the platform, providing the transport operator with a single point of access for managing and scaling their deployments.
“Autofleet’s platform provides impactful data that allows us to measure KPIs, and in turn improve our toolkit of services for future projects,” said Scheherazade Zekri, Director of New Mobility Services at Keolis Group. “The company’s work with us is crucial for developing new autonomous shuttle services that better manage fleets and serve commuters.”
“Autofleet's goal is to implement sustainable mobility services and support the transition of asset heavy fleets to Vehicle as a Service providers.” said Kobi Eisenberg, CEO at Autofleet. “We are excited to partner with Keolis on this project in order to execute autonomous operations in extreme conditions serving the transportation needs of communities globally.”
Autofleet offers fleet owners and operators a platform to automate and optimize fleet management for organizations and has partnered with other global fleets and manufacturers including Avis Budget Group, Zipcar, Keolis and Suzuki. In April 2020, Autofleet announced a capital raise totaling $7.5 million from its Series A, led by MizMaa Ventures, and seed financing, led by Maniv Mobility.
About Autofleet
Autofleet provides the leading Vehicle-as-a-Service platform for fleets to optimize existing operations and to seamlessly launch new business models from existing assets. The platform leverages advanced machine-learning algorithms for demand prediction, optimized placement and matching, automated pit-stop management and in/de-fleeting, and more. For more information, please visit https://www.autofleet.io/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210317005879/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Curatis: Double-Digit Revenue Growth in 2025 and Major Milestones for Corticorelin Achieved24.3.2026 07:00:00 CET | Press release
Curatis Holding AG (SIX:CURN, “Curatis”) reports business revenues of CHF 10.8m (+57%) for 2025. Curatis AG increased sales in its distribution business organically by 13%, from CHF 9.5m to CHF 10.8m. The net result improved from a loss of CHF 4.3m in 2024 to a loss of CHF 1.4m in 2025. Further key statements In September 2025, our development plan for corticorelin was validated at a meeting with the FDA, enabling Curatis to proceed toward a regulatory submission supporting a pivotal study in patients suffering from peritumoral brain edema (PTBE). In November 2025, Curatis raised CHF 1.2m to progress corticorelin. The cash position as of year end 2025 was comfortable, standing at CHF 1.9m. Recently, Curatis announced a license agreement for corticorelin for Japan with significant milestone payments. Business development and finances In 2025, product sales amounted to CHF 10.3m, while service revenue amounted to CHF 0.5m. On a full year basis, Curatis AG increased revenues in its distri
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs24.3.2026 07:00:00 CET | Press release
From its Therapeutic Dermatology portfolio, Galderma will present data on the efficacy and safety of Nemluvio® (nemolizumab) in different patient populations with moderate-to-severe atopic dermatitis, including late-breaking data in pediatric patients, and share four posters on AKLIEF® (trifarotene)1-8 Additional presentations related to Dermatological Skincare will explore how artificial intelligence can identify high-risk factors for sensitive skin and Cetaphil® in different skin types9 Data from Galderma’s Injectable Aesthetics portfolio will also show how its hyaluronic acid injectables, Restylane®, and neuromodulator, RelabotulinumtoxinA*, may address aesthetic needs across the face and décolletage10-14 A total of 22 presentations will reinforce the value of Galderma’s broad and comprehensive portfolio in meeting varied patient needs across Therapeutic Dermatology, Injectable Aesthetics and Dermatological Skincare Galderma (SIX: GALD), the pure-play dermatology category leader, wi
Avanzanite Expands French Operations and Appoints Constance Sabbagh as General Manager24.3.2026 07:00:00 CET | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced its expansion into France, Europe’s second largest economy, and the appointment of Constance Sabbagh as General Manager, France. Following a €32 million Series A investment by MVM Partners announced in November 2025, Avanzanite is scaling its European infrastructure into a single, integrated platform across 32 countries – designed to bring rare disease medicines to patients in every European market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323639110/en/ Constance Sabbagh, General Manager, France “France is essential to Avanzanite’s European vision,” said Adam Plich, Co-founder and CEO of Avanzanite. “With its leadership in rare disease policy through its National Rare Disease Plans, care networks and scientific innovation, France is one of the most significant healthcare
HJS Foundation Releases JEP Protocol & HJS Framework: The "Black Box" for AI, Enabling Verifiable Human Oversight24.3.2026 04:36:00 CET | Press release
HJS Foundation (Human Judgment Systems Foundation) today released two complementary solutions: the Judgment Event Protocol (JEP) and the Human Judgment Structure (HJS) framework. As a minimalist open standard, JEP generates tamper-proof records of AI decision accountability, just like an aircraft black box; HJS embeds human judgment logic into AI operation processes — together, they transform "human oversight" from a regulatory requirement into a verifiable technical fact, providing an optional technical solution for AI accountability. How to prove that AI decisions (such as loan approvals, medical diagnoses, border screenings, etc.) have undergone human review? JEP generates immutable audit trails of human intervention through four cryptographic primitives — Judge, Verify, Delegate, Terminate; HJS builds a controllable and accountable system to prevent risks such as AI drift and ensure that human judgment guides AI operations. Current systems rely on alterable post-hoc documentation,
Power Integrations Extends Flyback Topology to Enable 440 W, Offering Simpler Alternatives to Resonant Power Designs23.3.2026 22:45:00 CET | Press release
New TOPSwitchGaN ICs more than double power output, reducing system cost, complexity, and design time APEC 2026 – Power Integrations (NASDAQ: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today introduced a breakthrough in flyback topology extending the power range of flyback converters to 440 W—well beyond the limits that traditionally required more complex resonant and LLC topologies. The new TOPSwitchGaN™ flyback IC family unites the company’s groundbreaking PowiGaN™ technology with its iconic TOPSwitch™ IC architecture, reducing complexity, eliminating heat sinks in many cases, shortening design time, improving manufacturability, and lowering total system cost. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323686299/en/ The new TOPSwitchGaN™ flyback IC family extends the power range of flyback converters to 440 W—well beyond the limits that traditionally required more co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom